Literature DB >> 9574691

Recombinant mouse-human chimeric antibodies as calibrators in immunoassays that measure antibodies to Toxoplasma gondii.

J Hackett1, J Hoff-Velk, A Golden, J Brashear, J Robinson, M Rapp, M Klass, D H Ostrow, W Mandecki.   

Abstract

In the present study, we examined the feasibility of using recombinant antibodies containing murine variable regions and human constant regions as calibrators or controls in immunoassays. As a model system, we chose the Abbott IMx Toxo immunoglobulin M (IgM) and Toxo IgG assays designed to detect antibodies to Toxoplasma gondii. Two mouse monoclonal antibodies were selected based on their reactivity to the T. gondii antigens P30 and P66. Heavy- and light-chain variable-region genes were cloned from both hybridomas and transferred into immunoglobulin expression vectors containing human kappa and IgG1 or IgM constant regions. The constructs were stably transfected into Sp2/0-Ag14 cells. In the IMx Toxo IgG assay, immunoreactivity of the anti-P30 chimeric IgG1 antibody paralleled that of the positive human plasma-derived assay calibrators. Signal generated with the anti-P66 chimeric IgG1 antibody was observed to plateau below the maximal reactivity observed for the assay calibrator. Examination of the IgM chimeric antibodies in the IMx Toxo IgM assay revealed that both the anti-P30 and anti-P66 antibodies matched the assay index calibrator manufactured with human Toxo IgM-positive plasma. When evaluated with patient samples, the correlation between results obtained with the chimeric antibody calibrators and the positive human plasma calibrators was > or =0.985. These data demonstrate that chimeric mouse-human antibodies are a viable alternative to high-titer positive human plasma for the manufacture of calibrators and controls for diagnostic assays.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574691      PMCID: PMC104814          DOI: 10.1128/JCM.36.5.1277-1284.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Engineered human antibodies as immunologic quality control reagents.

Authors:  R G Hamilton
Journal:  Ann Biol Clin (Paris)       Date:  1990       Impact factor: 0.459

3.  Sequential determination of IgG subclasses and IgA specific antibodies in primary and reactivating toxoplasmosis.

Authors:  F Derouin; G Sulcebe; J J Ballet
Journal:  Biomed Pharmacother       Date:  1987       Impact factor: 6.529

4.  Production and properties of chimeric antibody molecules.

Authors:  S U Shin; S L Morrison
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

5.  Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis.

Authors:  O Liesenfeld; C Press; R Flanders; R Ramirez; J S Remington
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

6.  Production of functional chimaeric mouse/human antibody.

Authors:  G L Boulianne; N Hozumi; M J Shulman
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

7.  High-level expression of chimeric antibodies using adapted cDNA variable region cassettes.

Authors:  S D Gillies; K M Lo; J Wesolowski
Journal:  J Immunol Methods       Date:  1989-12-20       Impact factor: 2.303

8.  Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

Authors:  S L Morrison; M J Johnson; L A Herzenberg; V T Oi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies.

Authors:  S D Sharma; J Mullenax; F G Araujo; H A Erlich; J S Remington
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  The immunodominant epitope of the major membrane tachyzoite protein (P30) of Toxoplasma gondii.

Authors:  F Santoro; H Charif; A Capron
Journal:  Parasite Immunol       Date:  1986-11       Impact factor: 2.280

View more
  11 in total

1.  Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica.

Authors:  H Tachibana; X J Cheng; K Watanabe; M Takekoshi; F Maeda; S Aotsuka; Y Kaneda; T Takeuchi; S Ihara
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

3.  Development of human-murine chimeric immunoglobulin G for use in the serological detection of human flavivirus and alphavirus antibodies.

Authors:  Brett A Thibodeaux; Amanda N Panella; John T Roehrig
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

4.  A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.

Authors:  Brett A Thibodeaux; Nina C Garbino; Nathan M Liss; Joseph Piper; Jacob J Schlesinger; Carol D Blair; John T Roehrig
Journal:  Antiviral Res       Date:  2012-02-15       Impact factor: 5.970

5.  A humanized anti-DLL4 antibody promotes dysfunctional angiogenesis and inhibits breast tumor growth.

Authors:  Xuelian Jia; Wenyi Wang; Zhuobin Xu; Shijing Wang; Tong Wang; Min Wang; Min Wu
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

6.  Development of a human-murine chimeric immunoglobulin M antibody for use in the serological detection of human flavivirus antibodies.

Authors:  Brett A Thibodeaux; John T Roehrig
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

7.  Synthetic rabbit-human antibody conjugate as a control in immunoassays for immunoglobulin M specific to hepatitis E virus.

Authors:  Kuo Zhang; Lunan Wang; Min Liu; Rui Zhang; Jinming Li
Journal:  Virol J       Date:  2010-05-20       Impact factor: 4.099

8.  A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.

Authors:  Amanda E Calvert; Kandice L Dixon; Joseph Piper; Susan L Bennett; Brett A Thibodeaux; Alan D T Barrett; John T Roehrig; Carol D Blair
Journal:  Antiviral Res       Date:  2016-04-26       Impact factor: 5.970

9.  Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by Orientia tsutsugamushi).

Authors:  Martina L Jones; Ross T Barnard
Journal:  Clin Vaccine Immunol       Date:  2007-08-08

10.  Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.

Authors:  Bailin Tu; Robert N Ziemann; Bryan C Tieman; David J Hawksworth; Joan Tyner; James Scheffel; Mary S Pinkus; Susan E Brophy; Jeffrey M Werneke; Robin Gutierrez; Michael White
Journal:  Clin Vaccine Immunol       Date:  2010-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.